Order Entry
United Kingdom
ContactUsLinkComponent
Tanespimycin (17-AAG) is a potent HSP90 inhibitor with an IC50 of 5 nM, having a 100-fold higher binding affinity for tumour cell de rived HSP90 than normal cell derived HSP90[1][5]. Tanespimycin depletes cellular STK38/NDR1 and reduces STK38 kinase 1 * 10 mg
Catalog # MDEXHY-10211
Supplier:  MEDCHEMEXPRESS
Tanespimycin (17-AAG) is a potent HSP90 inhibitor with an IC50 of 5 nM, having a 100-fold higher binding affinity for tumour cell de rived HSP90 than normal cell derived HSP90[1][5]. Tanespimycin depletes cellular STK38/NDR1 and reduces STK38 kinase 1 * 10 mg
Catalog # MDEXHY-10211
Supplier:  MEDCHEMEXPRESS
Frequently Bought Together